Robert Davey

The Carpentries

Full Professor(heuristic)

Genomics and Phylogenetic Studies · Molecular Biology

Compare more Molecular Biology professors.

h-index23
i10-index36
Publications137
Citations4,106

Grants

13 total · 2 active

NIH #UC7AI095321

National Emerging Infectious Diseases Laboratories Operations

Expiring Soon
Amount
$11M–$12M
Period
2014-06-01 → 2026-10-31
PIs
1

Awarded at BOSTON UNIVERSITY MEDICAL CAMPUS

NIH #P01AI120943

Roles of host factor protein subnetworks in regulating steps of filovirus infection

Active
Amount
$500K–$600K
Period
2016-07-07 → 2028-05-31
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #R01AI128364

Antiviral Lead Identification to Treat Filovirus Infections

Amount
$700K–$800K
Period
2019-08-12 → 2023-07-31
PIs
2

Awarded at PURDUE UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

13 total · 2 active

NIH #UC7AI095321

National Emerging Infectious Diseases Laboratories Operations

Expiring Soon
Amount
$11M–$12M
Period
2014-06-01 → 2026-10-31
PIs
1

Awarded at BOSTON UNIVERSITY MEDICAL CAMPUS

NIH #P01AI120943

Roles of host factor protein subnetworks in regulating steps of filovirus infection

Active
Amount
$500K–$600K
Period
2016-07-07 → 2028-05-31
PIs
1

Awarded at WASHINGTON UNIVERSITY

NIH #R01AI128364

Antiviral Lead Identification to Treat Filovirus Infections

Amount
$700K–$800K
Period
2019-08-12 → 2023-07-31
PIs
2

Awarded at PURDUE UNIVERSITY

NIH #R01AI114814

Emerging virus-host cell protein interaction networks

Amount
$700K–$800K
Period
2015-05-04 → 2020-03-31
PIs
2

Awarded at PURDUE UNIVERSITY

NIH #R21TR001718

Repurposing pyronaridine as a treatment for the Ebola virus

Amount
$300K–$400K
Period
2016-09-23 → 2019-07-31
PIs
2

Awarded at COLLABORATIONS PHARMACEUTICALS, INC.

NIH #R21AI115082

Novel broad spectrum inhibitors of filovirus infection

Amount
$200K–$300K
Period
2015-08-24 → 2017-07-31
PIs
1

Awarded at TEXAS BIOMEDICAL RESEARCH INSTITUTE

NIH #R41AI115897

Development of a Broad Spectrum Antiviral for Ebola and Marburg viral Infections

Amount
$300K–$400K
Period
2015-02-01 → 2016-05-31
PIs
1

Awarded at OMM SCIENTIFIC, INC.

NIH #R56AI114814

Emerging virus-host cell protein interaction networks

Amount
<$100K
Period
2015-04-01 → 2015-04-30
PIs
2

Awarded at PURDUE UNIVERSITY

NIH #R03MH086850

HTS for Filo- and Arena-virus Entry Mechanisms

Amount
<$100K
Period
2009-09-30 → 2011-05-31
PIs
1

Awarded at UNIVERSITY OF TEXAS MED BR GALVESTON

NIH #R01AI063513

Receptor Trafficking in Entry of Murine Leukemia Viruses

Amount
$200K–$300K
Period
2006-05-15 → 2011-04-30
PIs
1

Awarded at UNIVERSITY OF TEXAS MED BR GALVESTON

NIH #R21GM076368

Nanoparticle Analysis of Enveloped Virus Entry Pathways

Amount
$200K–$300K
Period
2008-05-01 → 2010-04-30
PIs
1

Awarded at UNIVERSITY OF TEXAS MED BR GALVESTON

NIH #U54AI057156

Discovery and characterization of new therapeutics against filoviruses

Amount
$200K–$300K
Period
2008-03-01 → 2009-02-28
PIs
1

Awarded at UNIVERSITY OF TEXAS MED BR GALVESTON

NIH #R56AI063513

Receptor Trafficking in Entry of Murine Leukemia Viruses

Amount
$200K–$300K
Period
2005-07-15 → 2006-05-14
PIs
1

Awarded at UNIVERSITY OF TEXAS MED BR GALVESTON

Recent Public Signals

  1. New paper: The Carpentries Strategic Plan for 2026-2028 (Zenodo (CERN European Organization for Nuclear Research))2026-01-22
  2. New NIH award: Roles of host factor protein subnetworks in regulating steps of filovirus infection2016-07-07
  3. New NIH award: National Emerging Infectious Diseases Laboratories Operations2014-06-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-5589-7754

Professor Insights

Career Trajectory